Wells Fargo’s Guardant Health GH Stock Holding History

Wells Fargo’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-20,000	Closed	-$544K	–	7713
2022 Q4	$544K	Buy	+20,000	New	+$915K	﹤0.01%	3586
2022 Q3	–	Sell	-14,900	Closed	-$601K	–	6890
2022 Q2	$601K	Hold	14,900	–	–	﹤0.01%	3633
2022 Q1	$987K	Buy	+14,900	New	+$1.02M	﹤0.01%	3902
2021 Q3	–	Sell	-7,500	Closed	-$931K	–	7162
2021 Q2	$931K	Sell	7,500 -2,500	-25%	-$336K	﹤0.01%	4254
2021 Q1	$1.53M	Sell	10,000 -7,500	-43%	-$1.13M	﹤0.01%	3931
2020 Q4	$507K	Sell	17,500 -15,000	-46%	-$1.73M	﹤0.01%	4510
2020 Q3	$615K	Buy	+32,500	New	+$2.97M	﹤0.01%	4203

Other funds holding GH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wells Fargo's GH Position: Q1 2026 in Review

Wells Fargo reduced its Guardant Health (GH) stake by 57% in Q1 2026, selling an estimated $12.2M and leaving 92,549 shares worth $8.55M. The position accounts for ﹤0.01% of the portfolio, ranked #2164.

Wells Fargo first reported a position in GH in Q4 2018 and has held it in 30 quarters since. The position peaked at $216M in Q1 2021. 482 funds tracked by Wall St. Rank hold GH as of Q1 2026.

Wells Fargo held 92,549 shares of Guardant Health worth $8.55M as of Q1 2026.
Wells Fargo sold 121,628 Guardant Health shares in Q1 2026, an estimated $12.2M.
Guardant Health made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #2164 holding.
Wells Fargo first reported a position in Guardant Health in Q4 2018 and has held it in 30 quarters since.
Wells Fargo's Guardant Health position peaked at $216M in Q1 2021.
482 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.